Lob­by­ing cam­paign killed pro­pos­al to set price lim­its on fu­ture coro­n­avirus drugs, vac­cines — re­port

As Con­gress be­gan draft­ing the emer­gency, $8.3 bil­lion spend­ing bill to com­bat the coro­n­avirus out­break, De­moc­rats sought to wrap a string around some of that fund­ing.

With $3.1 bil­lion go­ing to sup­port phar­ma­ceu­ti­cal com­pa­nies in their R&D ef­forts against the out­break, pro­gres­sive law­mak­ers want­ed to en­sure that any drugs or vac­cines that emerged from those ef­forts would be priced af­ford­ably, Politi­co re­ports. That cam­paign failed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.